Medication Adherence in Patients With Inflammatory Bowel Disease (IBD)



Status:Completed
Conditions:Colitis, Irritable Bowel Syndrome (IBS), Gastrointestinal, Crohns Disease
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:18 - 80
Updated:10/3/2018
Start Date:June 2015
End Date:November 1, 2016

Use our guide to learn which trials are right for you!

Assessment of Health Literacy, Medication Adherence, and a Pilot Multi-component Intervention to Improve Medication Adherence in Patients With Inflammatory Bowel Disease

The purpose of this is to formally assess health literacy and medication adherence in
participants with Inflammatory bowel disease (IBD). The study also aims to improve medication
adherence, health-related quality of life, and disease activity through a 24-week
intervention.

The purpose of this study is to formally assess health literacy and medication adherence in
participants with Inflammatory bowel disease (IBD). The study also aims to improve medication
adherence, health-related quality of life, and disease activity through a 24-week
intervention that will include telephone reminders, educational materials, visits to the
physician, and financial counseling.

Inclusion Criteria:

- New or existing diagnosis of inflammatory bowel disease (IBD) proven via endoscopy,
pathology, and radiology findings

- Maintained or started on a medication for inflammatory bowel disease at the time of
enrollment

- Ability to speak English

- Good hearing

- Phone availability

Exclusion Criteria:

- Pregnancy or plans to be pregnant

- Inability to make own health care decisions

- Inability to participate in the study phone calls

- Uncontrolled psychiatric illness

- Enrollment in another clinical trial outside of the standard clinic IBD registry
We found this trial at
1
site
Atlanta, Georgia 30322
Principal Investigator: Heba Iskandar, MD
?
mi
from
Atlanta, GA
Click here to add this to my saved trials